Compare AFG & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AFG | HALO |
|---|---|---|
| Founded | 1872 | 1998 |
| Country | United States | United States |
| Employees | 8500 | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9B | 8.8B |
| IPO Year | N/A | 2001 |
| Metric | AFG | HALO |
|---|---|---|
| Price | $129.71 | $66.57 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 11 |
| Target Price | ★ $141.00 | $78.64 |
| AVG Volume (30 Days) | 349.1K | ★ 1.5M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.72% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.22 |
| Revenue | N/A | ★ $151,862,000.00 |
| Revenue This Year | N/A | $28.24 |
| Revenue Next Year | $4.44 | $12.56 |
| P/E Ratio | ★ $12.86 | $56.30 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $121.75 | $51.06 |
| 52 Week High | $150.02 | $82.22 |
| Indicator | AFG | HALO |
|---|---|---|
| Relative Strength Index (RSI) | 40.63 | 47.79 |
| Support Level | $129.99 | $62.53 |
| Resistance Level | $134.26 | $69.95 |
| Average True Range (ATR) | 2.45 | 2.55 |
| MACD | -0.49 | -0.07 |
| Stochastic Oscillator | 4.12 | 32.24 |
American Financial Group Inc is an insurance holding company. Through its subsidiaries, it is engaged in the property and casualty insurance business, focusing on specialized commercial products for businesses. The group operates through two segments: Property and Casualty Insurance, which generates maximum revenue, and Other. The Property and Casualty Insurance segment is further divided into different sub-segments, such as Property and transportation, Specialty casualty, and Specialty financial. These sub-segments offer insurance coverage for vehicles and commercial property, customized programs for small to mid-sized businesses, workers' compensation insurance, risk management insurance programs for lending and leasing institutions, trade credit insurance, and other insurance products.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.